SEGMENT REPORTING - Schedule of Reportable Segment Information and Reconciliation of Segment Information (Details) - USD ($) $ in Millions	12 Months Ended			24 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024
Segment Reporting Information [Line Items]
Net Sales	$ 7,104	$ 7,093	$ 7,389
Cost of products sold	3,891	4,045	4,481
Interest income	9	23	16
Interest expense	(88)	(90)	(90)
Loss on divestiture	(118)	(240)	0
Pension settlement charge	0	(171)	0
Cyberattack costs, net of insurance recoveries	70	(29)
VMS impairment	0	0	(445)
Streamlined operating model		(32)	(60)
Digital capabilities and productivity enhancements investment	(111)	(108)	(100)
Earnings before income taxes	1,078	398	238
(Income) Loss from equity investees included in Other (income) expense, net	(4)	(5)	(4)
Total assets	5,561	5,751		$ 5,751
Capital expenditures	220	212	228
Depreciation and amortization	219	235	236
Stock-based compensation	$ 81	$ 74	$ 73
Cyberattack | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage		100.00%
Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage	100.00%		100.00%	100.00%
Operating Segments
Segment Reporting Information [Line Items]
Net Sales	$ 7,066	$ 6,872	$ 7,149
Segment adjusted EBIT	1,565	1,354	1,275
Operating Segments | Health and Wellness
Segment Reporting Information [Line Items]
Net Sales	2,697	2,485	2,532
Cost of products sold	1,273	1,211	1,386
Other segment items	584	555	552
Segment adjusted EBIT	840	719	594
(Income) Loss from equity investees included in Other (income) expense, net	0	0	0
Total assets	1,217	1,124		$ 1,124
Capital expenditures	66	47	51
Depreciation and amortization	58	58	59
Stock-based compensation	$ 16	$ 14	$ 14
Operating Segments | Health and Wellness | Cyberattack | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage		30.00%
Operating Segments | Health and Wellness | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage	3.00%		6.00%	5.00%
Operating Segments | Household
Segment Reporting Information [Line Items]
Net Sales	$ 2,001	$ 1,950	$ 2,098
Cost of products sold	1,277	1,276	1,427
Other segment items	399	414	363
Segment adjusted EBIT	325	260	308
(Income) Loss from equity investees included in Other (income) expense, net	0	0	0
Total assets	1,091	1,088		$ 1,088
Capital expenditures	78	84	97
Depreciation and amortization	81	77	78
Stock-based compensation	$ 12	$ 11	$ 10
Operating Segments | Household | Cyberattack | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage		24.00%
Operating Segments | Household | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage	2.00%		1.00%	2.00%
Operating Segments | Lifestyle
Segment Reporting Information [Line Items]
Net Sales	$ 1,303	$ 1,275	$ 1,338
Cost of products sold	648	644	692
Other segment items	365	378	362
Segment adjusted EBIT	290	253	284
(Income) Loss from equity investees included in Other (income) expense, net	0	0	0
Total assets	1,103	1,110		$ 1,110
Capital expenditures	37	36	29
Depreciation and amortization	25	24	25
Stock-based compensation	$ 8	$ 8	$ 7
Operating Segments | Lifestyle | Cyberattack | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage		23.00%
Operating Segments | Lifestyle | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage	0.00%		4.00%	2.00%
Operating Segments | International
Segment Reporting Information [Line Items]
Net Sales	$ 1,065	$ 1,162	$ 1,181
Cost of products sold	668	743	792
Other segment items	287	297	300
Segment adjusted EBIT	110	122	89
(Income) Loss from equity investees included in Other (income) expense, net	(4)	(5)	(4)
Total assets	1,329	1,327		$ 1,327
Capital expenditures	26	21	24
Depreciation and amortization	42	45	46
Stock-based compensation	$ 6	$ 6	$ 4
Operating Segments | International | Cyberattack | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage		8.00%
Operating Segments | International | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage	4.00%		16.00%	11.00%
Corporate and Other
Segment Reporting Information [Line Items]
Net Sales	$ 38	$ 221	$ 240
Segment adjusted EBIT	(249)	(309)	(358)
(Income) Loss from equity investees included in Other (income) expense, net	0	0	0
Total assets	821	1,102		$ 1,102
Capital expenditures	13	24	27
Depreciation and amortization	13	31	28
Stock-based compensation	$ 39	$ 35	$ 38
Corporate and Other | Cyberattack | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage		15.00%
Corporate and Other | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration percentage	91.00%		73.00%	80.00%